(Q51843632)

13 April 2018

title

Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway. (English)

1 reference

13 April 2018

1 reference

Jingru Zhang

1

1 reference

13 April 2018

Jingjing Ye

2

1 reference

13 April 2018

Daoxin Ma

3

1 reference

13 April 2018

Na Liu

4

1 reference

13 April 2018

Hao Wu

5

1 reference

13 April 2018

Shuang Yu

6

1 reference

13 April 2018

Xiulian Sun

7

1 reference

13 April 2018

William Tse

8

1 reference

13 April 2018

Chunyan Ji

9

1 reference

13 April 2018

language of work or name

English

0 references

publication date

13 December 2012

1 reference

13 April 2018

published in

Carcinogenesis

1 reference

13 April 2018

volume

34

1 reference

13 April 2018

issue

3

1 reference

13 April 2018

page(s)

667-677

1 reference

13 April 2018

Contribution of bone microenvironment to leukemogenesis and leukemia progression

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Angiopoietin-2 predicts disease-free survival after allogeneic stem cell transplantation in patients with high-risk myeloid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Leukemia regression by vascular disruption and antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Angiogenesis in acute myeloid leukemia and opportunities for novel therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Influence of the tumor microenvironment on angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Primary human acute myeloid leukaemia cells increase the proliferation of microvascular endothelial cells through the release of soluble mediators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

The role of VEGF and a functional link between VEGF and p27Kip1 in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

The single-nucleotide polymorphisms +936 C/T VEGF and -710 C/T VEGFR1 are associated with breast cancer protection in a Spanish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Past, present and future of targeted therapy in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Antiangiogenic agents and targets: A perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Notch is oncogenic dominant in T-cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Notch signaling from tumor cells: a new mechanism of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Angiogenesis: a team effort coordinated by notch.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Up-regulation of endothelial delta-like 4 expression correlates with vessel maturation in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Modulation of VEGF signalling output by the Notch pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Notch modulates VEGF action in endothelial cells by inducing Matrix Metalloprotease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Notch1 regulates the effects of matrix metalloproteinase-9 on colitis-associated cancer in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Does serum soluble vascular endothelial growth factor levels have different importance in pediatric acute leukemia and malignant lymphoma patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Notch signaling maintains proliferation and survival of the HL60 human promyelocytic leukemia cell line and promotes the phosphorylation of the Rb protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

HESR1/CHF2 suppresses VEGFR2 transcription independent of binding to E-boxes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS386

Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1158/0008-5472.CAN-05-4281

Identifiers

DOI

10.1093/CARCIN/BGS386

1 reference

13 April 2018

1 reference

13 April 2018